These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25769966)

  • 1. Editorial: medicinal chemistry studies of neglected diseases.
    Scotti L; Scotti MT
    Mini Rev Med Chem; 2015; 15(3):180-1. PubMed ID: 25769966
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial (Thematic Issue: Medicinal Chemistry Applied to Natural Products in Neglected Drug Discovery).
    Scotti L; Scotti MT; Mendonça FJ
    Comb Chem High Throughput Screen; 2016; 19(7):514-5. PubMed ID: 27682866
    [No Abstract]   [Full Text] [Related]  

  • 3. Foreword. Trypanosomatid disease drug discovery and target identification.
    N Setzer W
    Future Med Chem; 2013 Oct; 5(15):1703-4. PubMed ID: 24144406
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug Design and Development for Neglected Diseases.
    Ferreira EI
    Curr Med Chem; 2019; 26(23):4298-4300. PubMed ID: 31618168
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrocycles as potential therapeutic agents in neglected diseases.
    Peña S; Scarone L; Serra G
    Future Med Chem; 2015; 7(3):355-82. PubMed ID: 25650721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From recipe to research: introducing undergraduate students to the nature of science using a hybrid practical course centred on drug discovery for neglected diseases.
    Wijtmans M; Edink E; van Linden OP; Zheng Y; Blaazer AR; Siderius M; van Muijlwijk-Koezen JE
    Drug Discov Today; 2021 Jun; 26(6):1359-1368. PubMed ID: 33609778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US incentive scheme for neglected diseases: a good idea gone wrong?
    Doshi P
    BMJ; 2014 Jul; 349():g4665. PubMed ID: 25099712
    [No Abstract]   [Full Text] [Related]  

  • 8. The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.
    Cheuka PM; Mayoka G; Mutai P; Chibale K
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28042865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for Antiprotozoal Activity in Herbal Medicinal Preparations; New Natural Leads against Neglected Tropical Diseases.
    Llurba Montesino N; Kaiser M; Brun R; Schmidt TJ
    Molecules; 2015 Aug; 20(8):14118-38. PubMed ID: 26248069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases.
    Ferreira LG; Oliva G; Andricopulo AD
    An Acad Bras Cienc; 2018; 90(1 Suppl 1):645-661. PubMed ID: 29451603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current bioanalytical methods for pharmacokinetic studies of drugs used in neglected tropical diseases.
    dos Santos Magalhães IR
    Bioanalysis; 2014; 6(12):1711-23. PubMed ID: 25077629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug design for neglected disease in Brazil.
    Giarolla J; Ferreira EI
    Mini Rev Med Chem; 2015; 15(3):220-42. PubMed ID: 25769971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I.
    Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
    Curr Med Chem; 2012; 19(14):2128-75. PubMed ID: 22414103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
    Bilbe G
    Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzymatic Studies in Medicinal Chemistry of Neglected Diseases.
    Scotti L; Scotti MT
    Curr Protein Pept Sci; 2016; 17(3):210-2. PubMed ID: 26983885
    [No Abstract]   [Full Text] [Related]  

  • 16. Dientamoeba fragilis, One of the Neglected Intestinal Protozoa.
    Garcia LS
    J Clin Microbiol; 2016 Sep; 54(9):2243-50. PubMed ID: 27053676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eliminating visceral leishmaniasis in South Asia: the road ahead.
    Rijal S; Sundar S; Mondal D; Das P; Alvar J; Boelaert M
    BMJ; 2019 Jan; 364():k5224. PubMed ID: 30670453
    [No Abstract]   [Full Text] [Related]  

  • 18. Conventional formulations and emerging delivery systems for the topical treatment of Cutaneous Leishmaniasis.
    Espuelas S
    Ther Deliv; 2015 Feb; 6(2):101-3. PubMed ID: 25690078
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II.
    Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
    Curr Med Chem; 2012; 19(14):2176-228. PubMed ID: 22414104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Studies on Neglected Drug Design.
    de Sousa NF; Scotti L; Rodrigues GCS; de Moura ÉP; Costa Barros RPB; Sessions ZL; Muratov EN; Scotti MT
    Curr Top Med Chem; 2021; 21(21):1943-1974. PubMed ID: 34544342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.